Ms. Amy Liang
Pharmaports LLC
1 E. Uwchlan Avenue, Suite 116
Exton, PA 19341

RE: The tariff classification of Etelcalcetide Hydrochloride (CAS No. 1334237-71-6) in bulk form, from Taiwan

Dear Ms. Liang:

In your letter dated July 28, 2017, you requested a tariff classification ruling.

Etelcalcetide Hydrochloride is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. It functions by binding to and activating the calcium-sensing receptor in the parathyroid gland.

The applicable subheading for the Etelcalcetide Hydrochloride in bulk form will be 2928.00.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Organic derivatives of hydrazine or of hydroxylamine: Other: Other: Drugs.” The rate of duty will be 3.7 percent ad valorem. Currently, Etelcalcetide is not listed in the Pharmaceutical Appendix to the Tarriff Schedule.

Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at

This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at

This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).

A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at


Steven A. Mack
National Commodity Specialist Division